L700-0295 Screening compound: 3-{5-[5-(6-chloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-1H-1,3-benzodiazol-1-yl}-1-(piperidin-1-yl)propan-1-one

L700-0295 Screening compound: 3-{5-[5-(6-chloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-1H-1,3-benzodiazol-1-yl}-1-(piperidin-1-yl)propan-1-one
L700-0295 Screening compound: 3-{5-[5-(6-chloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-1H-1,3-benzodiazol-1-yl}-1-(piperidin-1-yl)propan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L700-0295
3-{5-[5-(6-chloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-1H-1,3-benzodiazol-1-yl}-1-(piperidin-1-yl)propan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L700-0295

Molecular Formula

C22H21ClN6O2 (C22 H21 ClN6 O2)

Compound Name

3-{5-[5-(6-chloropyridin-3-yl)-1,2,4-oxadiazol-3-yl]-1H-1,3-benzodiazol-1-yl}-1-(piperidin-1-yl)propan-1-one

IUPAC name

3-{5-[5-(6-chloropyridin-3-yl)-124-oxadiazol-3-yl]-1H-13-benzodiazol-1-yl}-1-(piperidin-1-yl)propan-1-one

SMILES

O=C(CCn1c(ccc(-c2noc(-c(cc3)cnc3Cl)n2)c2)c2nc1)N1CCCCC1

InChI

InChI=1S/C22H21ClN6O2/c23-19-7-5-16(13-24-19)22-26-21(27-31-22)15-4-6-18-17(12-15)25-14-29(18)11-8-20(30)28-9-2-1-3-10-28/h4-7,12-14H,1-3,8-11H2

InChI Key

OTEPMLYTOYKRQC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27470737

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

436.9

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.232

Distribution Coefficient, logD

3.232

Water Solubility, LogSw

-3.57

Polar Surface Area

67.204

Acid Dissociation Constant (pKa)

23.24

Base Dissociation Constant (pKb)

3.08

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.80

L700-0295 in Drug Discovery

Included in Screening Libraries

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

Covalent Inhibitors Library (7986 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds
  • 3D
  • Fragments

References: we are preparing a list of scientific research reports with L700-0295 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L700-0295?
Check Price and Availability of L700-0295, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L700-0295 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L700-0295
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L700-0295
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L700-0295 available by request